TTN and familial dilated cardiomyopathy: Conversely, DCM with systolic dysfunction is associated with increased myofilament compliance and submaximal force generation, leading to speculation that titin-stiffening agents could enhance contractility and have therapeutic benefit in the context of HF with reduced ejection fraction (HFrEF) (6).